Breaking Down Shanghai Huayi Group Corporation Limited Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHH

Shanghai Huayi Group Corporation Limited (600623.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Peeling back the numbers behind Shanghai Huayi Group (600623.SS) reveals a company with mixed momentum: fiscal 2024 revenue rose to 44.65 billion CNY (up 9.27% year‑over‑year) yet trailing twelve‑month revenue as of Sept 30, 2025 slipped to 42.76 billion CNY (a 9.82% decline), driven by a Q3 2025 drop to 11.71 billion CNY from 12.98 billion CNY; profitability shows a 2024 net income of 910.64 million CNY (TTM 616.59 million CNY) with EPS 0.43 CNY in 2024 versus a TTM 0.30 CNY and slim operating margins/ROE around 1.61% and 4.19% respectively, while balance‑sheet and valuation metrics paint contrasting pictures - cash of 14.61 billion CNY (down from 16.36 billion CNY at year‑end 2024), a market cap of 15.45 billion CNY (up 13.75% YoY), P/S 0.36, P/B 0.72, TTM P/E 24.81 with forward P/E 13.16, EV/EBITDA 7.86, and a 2.44% dividend yield - set against rising net leverage (net debt/EBITDA 2.7x in 2022), planned capex of 5-7 billion CNY annually for the Guangxi Project, a Fitch BBB‑ Stable rating, and analysts' aggressive medium‑term projections (earnings growth 38.8% p.a., revenue 8% p.a., EPS growth 38.1% p.a. and ROE ~7.4% in three years) - read on to understand which of these data points matter most for investors weighing risk, valuation, liquidity and growth prospects.

Shanghai Huayi Group Corporation Limited (600623.SS) - Revenue Analysis

Shanghai Huayi Group Corporation Limited reported notable top-line movements across the last reporting periods, with FY2024 showing growth followed by a TTM deterioration into late 2025. Key headline figures and dynamics are summarized below.

Metric Value Change / Notes
Total revenue (FY ended 2024) 44.65 billion CNY +9.27% vs 40.86 billion CNY in FY2023
TTM revenue (as of 2025-09-30) 42.76 billion CNY -9.82% vs same TTM period 2024
Q3 revenue (2025) 11.71 billion CNY -9.75% vs Q3 2024 (12.98 billion CNY)
Market capitalization (2005) 4.98 billion CNY Base
Market capitalization (2025) 15.45 billion CNY 5‑year CAGR in market cap: 5.64%
Revenue per employee ≈3.99 million CNY Indicator of human capital efficiency
Price-to-Sales (P/S) ratio 0.36 Relatively low sales multiple
  • Drivers of FY2024 growth: stronger product mix and recovery in core industrial segments contributing to the 9.27% uplift versus FY2023.
  • Recent weakness: TTM decline mainly driven by a weaker Q3 2025 (‑9.75% year-over-year), signaling either volume softness or price pressure in the quarter.
  • Valuation context: P/S = 0.36 suggests the market prices the shares conservatively relative to sales-useful when comparing peers or assessing upside if revenues stabilize.
  • Operational efficiency: revenue per employee ~3.99 million CNY suggests solid revenue productivity per headcount.

For historical context on the company's evolution, ownership and business model, see: Shanghai Huayi Group Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

Shanghai Huayi Group Corporation Limited (600623.SS) - Profitability Metrics

The following presents key profitability metrics for Shanghai Huayi Group Corporation Limited (600623.SS), comparing fiscal year 2024 outcomes with more recent trailing twelve months (TTM) figures where available.
  • Net income (FY 2024): 910.64 million CNY, up 5.76% from 861.88 million CNY in FY 2023.
  • TTM net income (as of 2025-09-30): 616.59 million CNY, reflecting a decline versus FY 2024.
  • EPS (FY 2024): 0.43 CNY; TTM EPS (as of 2025-09-30): 0.30 CNY.
  • Operating margin (FY 2024): 1.61%; TTM operating margin (as of 2025-03-31): 1.61%.
  • ROA (FY 2024): 0.34%; TTM ROA (as of 2025-03-31): 0.34%.
  • ROE (FY 2024): 4.19%; TTM ROE (as of 2025-03-31): 4.19%.
Metric FY 2024 TTM (latest date) Change vs FY 2023 / Note
Net Income (CNY) 910.64M 616.59M (as of 2025-09-30) +5.76% vs FY 2023 (861.88M); TTM down vs FY 2024
Earnings Per Share (CNY) 0.43 0.30 (TTM as of 2025-09-30) TTM EPS lower than FY 2024
Operating Margin 1.61% 1.61% (TTM as of 2025-03-31) Stable at 1.61% in reported periods
Return on Assets (ROA) 0.34% 0.34% (TTM as of 2025-03-31) Flat across reported periods
Return on Equity (ROE) 4.19% 4.19% (TTM as of 2025-03-31) Consistent ROE in reported intervals

Shanghai Huayi Group Corporation Limited (600623.SS) - Debt vs. Equity Structure

Shanghai Huayi's balance between debt and equity is being actively shaped by large-scale capital investment in the Guangxi Project and by operating performance. Key arranger-level metrics and guidance help frame the company's leverage profile and near-term funding needs.
  • Net leverage (net debt / EBITDA) rose to 2.7x in 2022 from 1.9x in 2021, reflecting softer EBITDA generation and sustained capex for Guangxi Phase III.
  • Fitch Ratings affirmed the company's Long-Term IDR at 'BBB-' with a Stable Outlook, citing strong state ownership and potential government support.
  • Management guidance expects capital expenditures of CNY 5.0-7.0 billion per year over 2023-2025 to complete Phase III of the Guangxi Project, sustaining elevated funding requirements.
Metric 2021 2022 Guidance / Notes
Net leverage (Net debt / EBITDA) 1.9x 2.7x Increase due to moderating EBITDA and ongoing capex
Fitch Long-Term IDR BBB- (Stable) Affirmed by Fitch; state control cited as supportive
Annual capital expenditures (2023-2025) - CNY 5.0-7.0 billion per year for Guangxi Phase III
Debt-to-equity ratio Not disclosed Not explicitly provided in available sources
Interest coverage ratio Not disclosed Not explicitly provided in available sources
Total debt Not disclosed Not explicitly provided in available sources
Total equity Not disclosed Not explicitly provided in available sources
  • Implications for liquidity: sustained CNY 5-7bn p.a. capex implies continued funding need - likely a mix of internal cash flow and external debt; monitor quarterly cash flow and syndicated/CP issuances.
  • Credit profile: BBB- (Stable) suggests moderate creditworthiness with government support as a key positive; any deterioration in EBITDA or material cost overruns at Guangxi could pressure ratings.
  • Data gaps to watch: explicit debt-to-equity, interest coverage, and absolute debt/equity balances are not disclosed in available sources - investors should seek these figures from interim/annual reports or investor presentations.
  • Reference for management positioning and governance: Mission Statement, Vision, & Core Values (2026) of Shanghai Huayi Group Corporation Limited.

Shanghai Huayi Group Corporation Limited (600623.SS) - Liquidity and Solvency

Key balance-sheet liquidity data and solvency disclosures through mid-2025 show a modest decline in readily available cash while several ratio-based metrics are not explicitly disclosed in public sources.

  • Cash and cash equivalents (30-Jun-2025): 14.61 billion CNY (down from 16.36 billion CNY at 31-Dec-2024)
  • Current ratio: not explicitly provided in available sources
  • Quick ratio: not explicitly provided in available sources
  • Cash flow from operations: not explicitly provided in available sources
  • Free cash flow: not explicitly provided in available sources
  • Solvency ratio: not explicitly provided in available sources
Metric Value Notes / Source Status
Cash & Cash Equivalents (30-Jun-2025) 14.61 billion CNY Reported balance; reflects liquidity available mid-year
Cash & Cash Equivalents (31-Dec-2024) 16.36 billion CNY Prior-year year-end comparison
Current Ratio - Not explicitly provided in the available sources
Quick Ratio - Not explicitly provided in the available sources
Cash Flow from Operations (latest) - Not explicitly provided in the available sources
Free Cash Flow (latest) - Not explicitly provided in the available sources
Solvency Ratio - Not explicitly provided in the available sources

Implications for investors and monitoring priorities:

  • Track quarterly cash balances to see whether the decline from 16.36 bn to 14.61 bn CNY is a trend or a timing effect.
  • Seek disclosure of operating cash flow and free cash flow in upcoming reports to assess cash-generation capacity.
  • Request or calculate current and quick ratios when detailed current asset/liability breakdowns are available to evaluate short-term liquidity stress.
  • Monitor debt maturities and interest-bearing liabilities to infer solvency pressure in absence of an explicit solvency ratio.

For context on strategic priorities that may affect liquidity deployment, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Huayi Group Corporation Limited.

Shanghai Huayi Group Corporation Limited (600623.SS) - Valuation Analysis

An aggregate look at core valuation multiples shows a stock that on many fronts appears inexpensive relative to earnings and book value, while offering modest income to shareholders. Key market-implied measures (most recent) are listed below and interpreted for investor context.

  • TTM Price-to-Earnings (P/E): 24.81 - reflects recent earnings power; elevated vs. forward P/E suggests earnings improvement is expected.
  • Forward P/E: 13.16 - implies the market expects materially higher earnings over the next 12 months or a lower share price risk relative to TTM earnings.
  • Price-to-Book (P/B): 0.72 - the share price trades at a 28% discount to book value, indicating potential asset-based undervaluation or balance-sheet risk priced in by the market.
  • Enterprise Value / Revenue (EV/Rev): 0.42 - market values the firm at 42% of its annual revenue, consistent with heavy asset or commodity exposure where revenues are large but margins vary.
  • Enterprise Value / EBITDA (EV/EBITDA): 7.86 - implies about 7.9 years to cover enterprise value at current EBITDA, a moderate multiple for industrial/chemical peers.
  • Dividend yield: 2.44% (ex-dividend date: July 15, 2025) - provides a modest cash return alongside capital appreciation potential.
  • Market capitalization: 15.45 billion CNY (as of November 26, 2025) - up 13.75% year-over-year, signalling improved market sentiment or stronger fundamentals versus the prior year.
Metric Value Notes
TTM P/E 24.81 Based on trailing 12-month net income
Forward P/E 13.16 Implied by analyst consensus forward EPS
Price-to-Book (P/B) 0.72 Shares trade below book value
EV / Revenue 0.42 Enterprise value equals 42% of annual revenue
EV / EBITDA 7.86 Indicative payback period in years at current EBITDA
Dividend yield 2.44% Ex-dividend date: July 15, 2025
Market capitalization 15.45 billion CNY As of Nov 26, 2025; +13.75% YoY

Investor implications - how to read these signals:

  • Discounted P/B suggests balance-sheet value support; verify asset realizability and impairment risk.
  • Steep drop from TTM P/E to forward P/E indicates consensus earnings growth or one-off TTM weakness; check analyst drivers.
  • EV/Revenue at 0.42 and EV/EBITDA ~7.9 point to a capital-intensive business with moderate operating profitability; compare to chemical/industrial peers for context.
  • Dividend yield of 2.44% adds income but is not high enough alone to offset valuation risk - consider payout stability and free-cash-flow coverage.

For historical context on the company's strategy, structure and how it generates cash and earnings, see: Shanghai Huayi Group Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

Shanghai Huayi Group Corporation Limited (600623.SS) - Risk Factors

  • Commodity exposure: Shanghai Huayi operates significant commodity-chemical lines (basic petrochemicals, PVC, caustic soda, chlor-alkali derivatives). This creates higher cash-flow volatility versus specialty chemical peers-prices and margins can swing materially with feedstock and finished-goods cycles.
  • Guangxi Project capex pressure: The large-scale Guangxi integrated chemical project requires substantial upfront capital, pressuring near-term free cash flow and compressing reported profitability until full ramp-up.
  • State support reliance: The company benefits from strategic backing by the Shanghai SASAC; a reduction in state-related support, preferential financing or implicit guarantees would raise refinancing and operational risk.
  • Leverage and debt-service risk: Elevated gross and net debt levels increase sensitivity to interest-rate moves and restrict financial flexibility, potentially raising the company's cost of capital.
  • Input-price and macro sensitivity: Volatility in naphtha, ethylene, chlorine and other feedstock prices, plus global demand cycles, can materially affect margins and inventory valuation.
  • Operational, regulatory and environmental risk: Chemical-plant safety incidents, tighter emissions or environmental remediation requirements, and permit delays can cause unexpected costs or shutdowns.

Quantifying key risk-related metrics (most recent published fiscal year / management guidance):

Metric Value (approx.) Notes
Estimated annual revenue RMB 40-55 billion Varies by commodity cycle; company disclosures show material seasonality by segment.
Estimated EBITDA margin 8-14% Compressed during low-margin commodity cycles; higher when spreads widen.
Reported gross debt RMB 20-40 billion Includes bank loans, bonds and project financing; timing and structure affect short-term liquidity.
Net debt / EBITDA (approx.) 2.0-4.0x Range depends on EBITDA volatility and project‑phase capex.
Guangxi Project CAPEX (estimated) RMB 15-30 billion Large multi-year outlay-sizable portion financed by external debt and internal cash.
CAPEX run-rate (post-project) RMB 3-6 billion/yr Maintenance + growth; subject to board approvals.
  • Cash-flow volatility: When spreads narrow, working-capital swings and inventory write-downs can quickly reduce operating cash flow and increase short-term borrowing needs.
  • Refinancing and cost-of-capital sensitivity: With material project debt, rising market interest rates or reduced access to bank financing would increase interest expense and squeeze net income.
  • Concentration risk: Large-scale projects (e.g., Guangxi) concentrate execution, commissioning and market-acceptance risk in specific sites and product lines.
  • Regulatory & environmental compliance costs: Potential for higher-than-expected remediation, emission-control upgrades, or production curtailments under stricter Chinese environmental enforcement.
  • Market demand risk: A global slowdown (manufacturing/real estate cycles) reduces downstream demand for PVC, caustic soda, and other products, pressuring utilization and margins.

Management and investor considerations to monitor:

  • Quarterly capex disbursements and project milestone reporting for Guangxi (impact on liquidity and commissioning timelines).
  • Debt maturity schedule, interest-rate exposure (fixed vs. floating) and available committed credit lines.
  • Inventory valuation methods and days of inventory-higher days signal greater exposure to price swings.
  • Environmental capital expenditures and any disclosed contingent liabilities or fines.
  • Statements from Shanghai SASAC or related bodies regarding continued support or strategic directives.

For background on the company's broader strategy, ownership and how it makes money see: Shanghai Huayi Group Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

Shanghai Huayi Group Corporation Limited (600623.SS) - Growth Opportunities

Shanghai Huayi Group Corporation Limited (600623.SS) presents a mix of high earnings growth forecasts, targeted project expansion and strategic bets in high-growth chemical segments that investors should watch.
  • Analyst forecasts: earnings growth of 38.8% p.a. and revenue growth of 8.0% p.a. over the next three years.
  • EPS is expected to increase by 38.1% p.a. over the same period, reflecting margin expansion or earnings leverage.
  • Return on equity is forecasted at 7.4% in three years, indicating moderate capital efficiency improvement from current levels.
Metric Current / Base Year 1 (proj) Year 2 (proj) Year 3 (proj)
Revenue growth (annual) - +8.0% +8.0% +8.0%
Earnings growth (annual) - +38.8% +38.8% +38.8%
EPS growth (annual) - +38.1% +38.1% +38.1%
ROE (forecast) Current: (reported level varies) - - 7.4%
  • Guangxi Project expansion: a material near-term capacity driver - expected to bolster chemical output and create incremental revenue streams tied to specialty chemicals and intermediates.
  • R&D and government subsidies: ongoing investment in innovation, with subsidy support improving return on new product development and accelerating commercialization timelines.
  • Green tire and energy chemicals: strategic focus areas positioned to capture structural demand from automotive electrification, sustainable materials adoption and energy transition policies.
Key investor angles include scaling earnings at ~38.8% p.a. while top-line rises at ~8% p.a., a potential EPS multiplier effect from operational gearing, and the role of the Guangxi Project plus R&D/subsidies in delivering differentiated product offerings and margin upside. For a deeper look at shareholder composition and recent trading interest, see: Exploring Shanghai Huayi Group Corporation Limited Investor Profile: Who's Buying and Why?

DCF model

Shanghai Huayi Group Corporation Limited (600623.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.